Clinical Trials in New York

Showing 4621-4640 of 22,668 trials

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

NCT07011771

The goal of this clinical trial is to learn about the safety of CAP-003 gene therapy in adults with GBA1 associated Parkinson's Disease. It will also provide information about whether CAP-003 demonstrates efficacy in these adults. Participants will have a single intravenous infusion of CAP-003 and visit the clinic regularly for 2 years for checkups and tests.

GBA1 Parkinson Disease

Capsida Biotherapeutics, Inc.31 participantsStarted Aug 2025

Chicago, Illinois, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +3 more locations

COMPLETEDPhase 2< 1 mile

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

NCT05307328

This is a randomized, placebo-controlled, study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome caused by a non-adrenal tumor. Subjects will receive each of the following 2 treatments for 24 weeks: SPI-62 and matching placebo with the option of long-term extension.

Cushing's Syndrome ICushing Disease Due to Increased ACTH SecretionCortisol Excess+3 more

Sparrow Pharmaceuticals26 participantsStarted Sep 2022

Phoenix, Arizona, United States • Fort Myers, Florida, United States • Rochester, Minnesota, United States +9 more locations

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

Find Trials by Condition in New York

A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Improving Patient Prioritization During Hospital-homecare Transition

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Laser Ablation of Papillary Thyroid Microcarcinoma

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Cognitive Remediation for Coordinated Specialty Care

Kaneka Endovascular Embolization and Protection

Tislelizumab in People With Colorectal Cancer

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen

KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

Futibatinib in Patients With Specific FGFR Aberrations

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer